Alembic Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
APLLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alembic Pharmaceuticals has submitted a routine compliance certificate to the stock exchanges for the quarter ended 30th June 2025. The certificate was issued by its Registrar and Share Transfer Agent, MUFG Intime India Private Limited (formerly Link Intime India). It confirms that all share dematerialisation requests received from depository participants during the quarter were properly processed, listed on the stock exchanges, and reflected in the company's register of members within SEBI's prescribed timelines. This is a standard quarterly filing mandated under Regulation 74(5) and contains no new business or financial information.
This is a routine regulatory compliance filing with no material impact on the company's operations, financials, or share price. Shareholders do not need to take any action.